Tabular Research
Database Table Name: Global market size for number of prescriptions and US dollar sales of COX inhibitors for 1999 and forecast for 2000 through 2004, with ...
Datamonitor, Oct 2003, Pages: 32
... of unique challenges to pharmaceutical companies THE FAILURE OF COX-II INHIBITORS IN EUROPE European sales of COX-II inhibitors have disappointed ...
Lead Discovery, Oct 2004, Pages: 59
... the efficacy, gastrointestinal safety and cardiovascular risk of the COX-2 inhibitors -Predict the future sales of COX-2 inhibitors -Introduce alternatives for ...
Lead Discovery, Nov 2004, Pages: 59
... on thrombosis Unanswered questions 7. Knock-on effect of Vioxx's withdrawal - Estimated sales performance of other COX-2 inhibitors <BR ...
Tabular Research ... for 1999 and forecast for 2000 to 2003, with breakout of prescription numbers, dollar sales and percent market share data for COX-2 inhibitors, Database Table ...
Business Insights, June 2006, Pages: 206
... market, 2005?11 Table 2.27: Leading COX-II inhibitor brands in the global pain market, 2004?05 Table 2.28: Sales forecasts for COX-II inhibitors, 2005?11 ...
Tabular Research ... in US dollars, with breakout of sales and percent market share for Celebrex / Valdecoxib and Vioxx / Etoricoxib coxib ( COX-2 specific inhibitor ) drugs in ...
Business Insights, July 2007, Pages: 216
... of topical antirheumatics Leading brands of topical antirheumatics Topical antirheumatic sales forecasts to 2012 COX-II inhibitors Competitive dynamics of ...
Datamonitor, Dec 2006, Pages: 155
... Scope of this title: - Sales and volume forecasts for the leading ... future strategies companies will use for advertising and marketing COX-2 inhibitors and the ...
Espicom Business Intelligence Ltd, March 2008, Pages: 250
... and Pfizer's Bextra has seen a slowdown in the uptake of Cox-2 inhibitors in the ... Enbrel, Remicade and Humira ? who will win the battle for sales, and why? ...
Datamonitor, July 2003, Pages: 129
... strong competitor for Pfizer/Pharmacia in the future and the Cox-ii inhibitor class will ... will enable Amgen to regain a significant portion of sales lost to ...
Datamonitor, Dec 2003, Pages: 235
... BR>Report Highlights COX-2 inhibitors are used ... DTC advertising, the high prices of COX-2s and ... Use prescription rates to predict product sales across the ...
Business Monitor International, Nov 2007, Pages: 114
... Includes SSRI, SNRI And Newer Generation) - Total US Sales $ In Thousands (000) Table: Antiarthitics, COX-2 Inhibitors - Total US Sales $ In Thousands (000 ...
Datamonitor, Nov 2006, Pages: 199
... positioning analysis of Prexige for OA, 2006 82 Figure 12: Comparison of IC50s of NSAIDs and COX-2 inhibitor 83 Figure 13: Our forecast of OA sales for Prexige ...
Datamonitor, May 2002 ... Though sales revenues for these opioid products will be low compared to COX-II inhibitors, return on investment will be high due to reduced research and ...
Business Monitor International, May 2008, Pages: 110
... Antidepressants (includes SSRI, SNRI and newer generation) - Total US Sales (US$?000) Table: Antiarthitics, COX-2 Inhibitors - Total US Sales (US$?000 ...
Business Monitor International, Feb 2008, Pages: 113
... Antidepressants (includes SSRI, SNRI and newer generation) - Total US Sales (US$?000) 85 Table: Antiarthitics, COX-2 Inhibitors - Total US Sales (US$?000 ...
